NIRAPARIB CAPSULES 100 MG * NIRAPARIB TOSYLATE MONOHYDRATE, FORMULATED

Physical hazards

Not classified.

Health hazards

Acute toxicity, oral Category 4 Germ cell mutagenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 1 exposure

Environmental hazards

Hazardous to the aquatic environment, acute Category 2 Hazardous to the aquatic environment, Category 1

Long term hazards

OSHA defined hazards Not classified.

Signal word

Danger

Hazard statements

Harmful if swallowed. Suspected of causing genetic defects. Suspected of damaging fertility or the unborn child. Causes damage to organs through prolonged or repeated exposure. Toxic to aquatic life. Very toxic to aquatic life with long lasting effects.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.

Response

If swallowed: Call a poison center/doctor/physician/ if you feel unwell. Rinse mouth. If exposed or concerned: Get medical advice/attention. Collect spillage.

Storage

Store locked up.

Disposal

Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on

Classified (HNOC)

health hazards.

Additional information

99.5% of the mixture consists of component(s) of unknown acute dermal toxicity. 61.18% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 61.18% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.